Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Other Non Operating Income: 2019-2025

Historic Other Non Operating Income for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $409,000.

  • Biodesix's Other Non Operating Income rose 9.36% to $409,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $932,000, marking a year-over-year increase of 1342.67%. This contributed to the annual value of -$248,000 for FY2024, which is 4233.33% down from last year.
  • According to the latest figures from Q3 2025, Biodesix's Other Non Operating Income is $409,000, which was up 701.96% from $51,000 recorded in Q2 2025.
  • In the past 5 years, Biodesix's Other Non Operating Income ranged from a high of $3.1 million in Q3 2021 and a low of -$6.4 million during Q4 2022.
  • Its 3-year average for Other Non Operating Income is $48,700, with a median of $2,000 in 2023.
  • Over the last 5 years, Biodesix's Other Non Operating Income had its largest YoY gain of 18,600.00% in 2024, and its largest YoY loss of 38,800.00% in 2024.
  • Quarterly analysis of 5 years shows Biodesix's Other Non Operating Income stood at -$97,000 in 2021, then plummeted by 6,547.42% to -$6.4 million in 2022, then soared by 100.03% to $2,000 in 2023, then soared by 18,600.00% to $374,000 in 2024, then climbed by 9.36% to $409,000 in 2025.
  • Its Other Non Operating Income was $409,000 in Q3 2025, compared to $51,000 in Q2 2025 and $98,000 in Q1 2025.